Delivery Order SPE2D121D7001-SPE2D526F5355
- Not listed
- Masimo Corporation, a global medical technology company specializing in noninvasive patient monitoring solutions, was awarded a firm fixed-price delivery order valued at $1,261.00 by the Defense Logistics Agency's Medical Supply Chain on January 22, 2026. This delivery order, designated as contract number 4570604938, calls for the delivery of PHASEIN EMMA capnograph equipment, with performance to be completed at Masimo's Irvine, California facility by February 5, 2026. The award was made through...
- Masimo Corporation, a global medical technology company headquartered in Irvine, California, was awarded a delivery order contract valued at $3,783.00 by the Medical Supply Chain, a defense-focused federal agency, for the provision of PHASEIN EMMA capnographs. The contract, issued on June 2, 2025, operates under firm fixed-price terms with an ultimate completion date of June 16, 2025, and will be fulfilled at Masimo's facility in Irvine, California. No set-aside designation was applied to this...
- Masimo Corporation received a firm fixed-price delivery order valued at $1,261.00 from the Defense Logistics Agency's Medical Supply Chain division for PHASEIN EMMA capnographs, awarded on August 3, 2025, with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation, indicating full and open competition. Performance will take place at Masimo's facility in Irvine, California. As a global medical technology company specializing in noninvasive patient monitoring...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,261 firm fixed-price delivery order to Masimo Corporation for EMMA capnographs on August 4, 2025, with an ultimate completion date of August 18, 2025. Masimo, a global medical technology company headquartered in Irvine, California, will perform this work at its Irvine, CA facility. The contract was awarded without a set-aside designation, indicating full and open competition. Capnographs are noninvasive patient monitoring...
- Masimo Corporation, a global medical technology company headquartered in Irvine, California, was awarded a firm fixed-price delivery order valued at $7,566.00 by the Defense Logistics Agency's Medical Supply Chain division on September 12, 2025. The contract, which carries no set-aside designation and represents full and open competition, involves the delivery of EMMA capnographs—noninvasive respiratory monitoring devices used to measure exhaled carbon dioxide. Performance will be completed at...
- Masimo Corporation, a global medical technology company based in Irvine, California, has been awarded a delivery order valued at $3,783.00 for a monitoring kit containing end-tidal carbon dioxide (EMMA) equipment and lightweight component accessories. This firm fixed-price delivery order, issued on November 4, 2025, with an ultimate completion date of November 19, 2025, represents routine replenishment of specialized respiratory monitoring supplies for federal healthcare operations. The award...
- The Department of Defense's Medical Supply Chain awarded Masimo Corporation a $14.4K firm fixed-price delivery order on August 20, 2025, for PHASEIN EMMA capnograph equipment, with completion scheduled for September 4, 2025. This delivery order was awarded without set-aside designation, indicating full and open competition. The work will be performed at Masimo's facility in Irvine, California. As a established supplier of noninvasive patient monitoring solutions to federal healthcare systems,...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,261.00 to Masimo Corporation, a global medical technology company headquartered in Irvine, California. The contract, issued on August 5, 2025, with an ultimate completion date of August 19, 2025, calls for the delivery of an EMMA capnograph, a noninvasive patient monitoring device used for respiratory status assessment. The award was made on a firm fixed-price basis with no set-aside designation, indicating...
- Masimo Corporation was awarded a delivery order valued at $2,522.00 by the Defense Logistics Agency's Medical Supply Chain on December 30, 2025, for the provision of EMMA capnographs with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order, which carries no set-aside designation, represents a routine replenishment of medical monitoring equipment to support federal healthcare operations. The work will be performed at Masimo's headquarters location in Irvine,...
- Masimo Corporation, a leading global medical technology company headquartered in Irvine, California, was awarded a delivery order valued at $3,783.00 by the Defense Department's Medical Supply Chain on July 24, 2025. The contract calls for delivery of EMMA capnographs—advanced respiratory monitoring devices used for measuring end-tidal carbon dioxide levels in patient care settings—with a firm fixed-price structure and no set-aside designation, indicating full and open competition. The place...
- SPE2D121D7001Indefinite Delivery Contract
- SPE2D121D7001-SPE2D526F5355Delivery Order
Masimo Corporation was awarded a firm fixed-price delivery order valued at $1,261.00 by the Defense Logistics Agency's Medical Supply Chain for the delivery of PHASEIN EMMA capnographs. The contract was awarded on January 21, 2026, with an ultimate completion date of February 4, 2026, and will be performed in Irvine, California. No set-aside designation was used in this competitive award. Capnographs are critical patient monitoring devices that measure end-tidal carbon dioxide levels, providing essential respiratory status information for medical personnel in military and healthcare settings. This delivery order represents routine replenishment procurement under the established federal contracting relationship between Masimo and the Defense Logistics Agency's Medical Supply Chain. As a specialized medical technology provider headquartered in Irvine, California, Masimo has maintained an extensive portfolio of federal contracts since 2002, supplying sophisticated monitoring equipment including pulse oximeters, respiratory monitoring accessories, and diagnostic sensors to military and veteran healthcare facilities. The company's consistent receipt of firm fixed-price delivery orders throughout 2025 reflects its established competitive standing as a primary supplier of medical monitoring technologies to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/20/26 |